Parkinson's-on-Chip Model (PoCM): An Early Proteotoxicity Screening Model of Prion-like Propagation in Alpha-synuclein Related Neurodegeneration
Description of the granted funding
Parkinson's-on-chip model (PoCM): Electrophysiological modeling of prion-like propagation in alpha-synuclein related neurodegeneration. Parkinson's disease (PD) is a degenerative disorder of the central nervous system (CNS). It is the second most common neurodegenerative disease without absolute cure. Disease has progressive effects on patient's CNS, which gradually influence the life quality negatively. For this reason, it is very important to develop early disease markers both for diagnostic and novel therapeutics. Here, integrated PoCM model is built by combining PD neurons with microfluidics and microelectrode array (MEA) chips. Both axonal and neuronal network level (dys)functionality are monitored and temporally defined in relation to disease progression. The project offers novel innovative techniques to understand the disease propagation mechanisms and develop early disease markers. Main aim is to broaden our perspective to improve therapeutic approaches.
Show moreStarting year
2020
End year
2023
Granted funding
Funder
Research Council of Finland
Funding instrument
Postdoctoral Researcher
Other information
Funding decision number
332693
Fields of science
Neurosciences
Research fields
Molekyyli- ja solutason neurotiede
Identified topics
brain, neuroscience